Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 537 of 1,261

  1. US 10105376

    Omega-3 compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  2. US 10106579

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  3. US 10105416

    Methods of treating mild brain injury

    The Regents of the University of California · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  4. US 10106556

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  5. US 10106569

    Inhibitors of sodium glucose transporter 1 for constipation

    LEXICON PHARMACEUTICALS, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  6. US 10106538

    Inhibitors of protein kinases

    Princeton Drug Discovery, Inc · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  7. US 10106540

    HDAC6 inhibitors and their uses

    Universität Regensburg · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  8. US 10106581

    Cyclic peptidomimetic compounds as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  9. US 10106650

    Reversibly crosslinked micelle systems

    The Regents of the University of California · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  10. US 10105448

    Combined enteropathogen recombinant construct

    United States of America as represented by the Secretary of the Air Force · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  11. US 10105523

    Implantable drug delivery device

    Nano Precision Medical, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  12. US 10105436

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  13. US 10105392

    Isolated renal cells and uses thereof

    inRegen · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  14. US 10105411

    Compositions and methods for modulating AT2R activity

    NOVOPYXIS INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  15. US 10105409

    Therapeutic use of chardonnay seed products

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  16. US 10105341

    Treatment for obesity

    Jazz Pharmaceuticals International III Limited · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  17. US 10106500

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  18. US 10105354

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  19. US 10105408

    Traditional Chinese medicine composition and preparation method and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  20. US 10105434

    Immune enhancing recombinant dengue protein

    United States of America as represented by the Secretary of the Air Force · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  21. US 10106503

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  22. US 10106592

    Interleukin-4 receptor-binding fusion proteins and uses thereof

    Medicenna Therapeutics Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  23. US 10107816

    G-protein coupled receptor-associated diagnostics and therapeutics for B-cell chronic lymphocytic leukemia

    The Regents of the University of California · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  24. US 10106796

    Compound and method for treating myotonic dystrophy

    Sarepta Therapeutics, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.